| Code | Description | Claims | Beneficiaries | Total Paid |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,055 |
2,748 |
$127K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,644 |
3,264 |
$86K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
710 |
685 |
$34K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,948 |
1,764 |
$32K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,157 |
3,637 |
$32K |
| 80053 |
Comprehensive metabolic panel |
2,824 |
2,534 |
$29K |
| 80061 |
Lipid panel |
1,879 |
1,723 |
$25K |
| 80074 |
|
396 |
383 |
$19K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,547 |
742 |
$16K |
| 86328 |
|
690 |
651 |
$13K |
| 36415 |
Collection of venous blood by venipuncture |
1,463 |
1,331 |
$11K |
| 86769 |
|
476 |
431 |
$11K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,033 |
942 |
$10K |
| 86738 |
|
701 |
673 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
317 |
295 |
$9K |
| 81000 |
|
2,273 |
2,056 |
$7K |
| 86701 |
|
539 |
525 |
$5K |
| 84439 |
|
253 |
214 |
$2K |
| 86592 |
|
481 |
468 |
$2K |
| 84436 |
|
264 |
256 |
$2K |
| 87400 |
|
129 |
82 |
$2K |
| 82274 |
|
59 |
59 |
$957.03 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
97 |
97 |
$817.25 |
| 82043 |
|
125 |
122 |
$739.56 |
| 87088 |
|
69 |
69 |
$587.78 |
| 82607 |
|
35 |
24 |
$562.85 |
| 81001 |
|
125 |
119 |
$381.15 |
| 85027 |
|
12 |
12 |
$57.95 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
79 |
61 |
$0.00 |